Chembio Diagnostics (CEMI) Appoints Leslie Teso-Lichtman to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. META
5. FICO
6. GMAB
7. ACCV
8. LLY
9. TSLA
10. SPCX

Go back to Chembio Diagnostics (CEMI) Appoints Leslie Teso-Lichtman to its Board

Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

May 24, 2022 4:15 PM EDT

HAUPPAUGE, N.Y., May 24, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the election of Leslie Teso-Lichtman to its Board of Directors at Chembios 2022 Annual Meeting of Stockholders.

We are excited to have Leslie join the Chembio Board of Directors, said Richard Eberly, Chembios Chief Executive Officer and President. Her significant experience in corporate financial leadership at global diagnostics companies will be an important asset as we strive to create value through our Global Competitiveness program by leveraging Chembios broad product portfolio and operations worldwide.

Ms.... More